Clinical performance of the atrial fibrillation in the Russian population depending on the antithrombotic therapy: findings from the GLORIA-AF registry phase 2

Aim. To analyze clinical characteristics of patients with nonvalvular atrial fibrillation (AF) in the Russian population, enrolled in the GLORIA-AF registry phase 2, depending on the antithrombotic therapy received, and to assess the potential for patient retention with dabigatran during a 2-year fo...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	E. V. Shlyakhto, S. V. Villevalde, A. V. Ezhov, S. A. Zenin, N. A. Koziolova, O. Yu. Korennova, T. N. Novikova, K. V. Protasov, G. A. Chumakova, C. Teutsch, S. Lu, G. Y. H. Lip, M. V. Huisman
Materiálatiipa:	Artigo
Giella:	Russo
Almmustuhtton:	«FIRMA «SILICEA» LLC 2020-12-01
Ráidu:	Российский кардиологический журнал
Fáttát:	atrial fibrillation gloria-af registry dabigatran etexilate therapy retention
Liŋkkat:	https://russjcardiol.elpub.ru/jour/article/view/4179
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!